These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

27 related articles for article (PubMed ID: 6538775)

  • 1. Prevalence of Cytoplasmic Actin Mutations in Diffuse Large B-Cell Lymphoma and Multiple Myeloma: A Functional Assessment Based on Actin Three-Dimensional Structures.
    Witjes L; Van Troys M; Verhasselt B; Ampe C
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32349449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mutation in actin associated with neoplastic transformation.
    Kakunaga T; Leavitt J; Hamada H
    Fed Proc; 1984 May; 43(8):2275-9. PubMed ID: 6201399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Malignant transformation and alteration of actin-related proteins].
    Kakunaga T
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 2):1996-2001. PubMed ID: 3606134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutated-gamma-actin restores growth to a yeast amino acid transport defective mutant.
    Khamessan A; Naghibalhossaini F; Vedadi M; Johnstone RM
    J Cell Physiol; 2001 Jan; 186(1):124-35. PubMed ID: 11147807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of anchorage independent growth and serum resistance in immortalized human bronchial epithelial cells by alteration of the cytoskeleton.
    De Silva R; Englezou A; Schevzov G; Gerwin BI; Harris CC; Gunning P; Reddel RR
    Cell Mol Biol Res; 1994; 40(4):323-35. PubMed ID: 7866433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor beta 1 suppresses transformation in hepatocytes by regulating alpha 1 beta 1 integrin expression.
    Serra R; Carbonetto S; Lord M; Isom HC
    Cell Growth Differ; 1994 May; 5(5):509-17. PubMed ID: 8049157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of actin alteration in the neoplastic transformation].
    Kakunaga T
    Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):629-37. PubMed ID: 6538775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G proteins, phosphoinositides, and actin-cytoskeleton in the control of cancer growth.
    Maruta H; He H; Tikoo A; Vuong T; Nur-E-Kamal M
    Microsc Res Tech; 1999 Oct; 47(1):61-6. PubMed ID: 10506762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dictyostelium as model system for studies of the actin cytoskeleton by molecular genetics.
    Eichinger L; Lee SS; Schleicher M
    Microsc Res Tech; 1999 Oct; 47(2):124-34. PubMed ID: 10523791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Actin, its associated proteins and metastasis.
    Button E; Shapland C; Lawson D
    Cell Motil Cytoskeleton; 1995; 30(4):247-51. PubMed ID: 7796455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microfilament actin remodeling as a potential target for cancer drug development.
    Rao J; Li N
    Curr Cancer Drug Targets; 2004 Jun; 4(4):345-54. PubMed ID: 15180500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Actin cytoskeletal network in aging and cancer.
    Rao KM; Cohen HJ
    Mutat Res; 1991; 256(2-6):139-48. PubMed ID: 1722006
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.